ADIL Award Disclosure
Davidson Matt · SEC Form 4 · Filed Oct 30, 2026
Award
Reported value range
Not reported
Davidson Matt President And CEO
ADIL
Transaction date
Oct 28, 2026
Public filing date
Oct 30, 2026
Filing lag
Filed 2 days later
ADIL daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 333,830 shares
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001213900-26-114588
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Adial Pharmaceuticals, Inc. ADIL Current | Award | Oct 28, 2026 | Not reported |
| Adial Pharmaceuticals, Inc. ADIL | Award | Oct 28, 2026 | $0 |
| Adial Pharmaceuticals, Inc. ADIL | Award | Oct 28, 2026 | Not reported |
| Adial Pharmaceuticals, Inc. ADIL | Award | Oct 28, 2026 | $0 |
| Adial Pharmaceuticals, Inc. ADIL | Award | Oct 28, 2026 | Not reported |
| Adial Pharmaceuticals, Inc. ADIL | Award | Oct 28, 2026 | Not reported |
| Adial Pharmaceuticals, Inc. ADIL | Award | Oct 28, 2026 | Not reported |